US Stocks
/
Avalo Therapeutics, Inc. Share Price

Avalo Therapeutics, Inc. Share Price

NASDAQ: AVTX | Micro Cap
$18.34
-$0.39 (-2.08%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Avalo Therapeutics, Inc. Stock Performance

Open
$18.86
Prev. Close
$18.73
Circuit Range
N/A
Day Range
$17.90 - $18.86
Year Range
$8.23 - $24.23
Volume
48,685
Average Traded
$18.24

Avalo Therapeutics, Inc. Share Price Today

As of 10 August 2026, Avalo Therapeutics, Inc.'s share price is $18.34. The stock opened at $18.86, compared to its previous close of $18.73. During today's trading session, Avalo Therapeutics, Inc.'s share price traded between $17.90 and $18.86, with an average price of $18.38. Over the past 52 weeks, the stock has recorded a high of $24.23 and a low of $8.23. In terms of performance, Avalo Therapeutics, Inc.'s share price has risen by 4.32% over the last six months and is up 100.00% on a year-on-year basis.

Avalo Therapeutics, Inc. Share Price Chart

$17.90$18.86
L
Show Current Price
H

Avalo Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$245.84M
PE Ratio (TTM)
-3.14
Dividend Yield
N/A
EPS (TTM)
$-5.84
Revenue (TTM)
$59000.00
Return On Equity (TTM)
-94.23%
Profit Margin
-132642.37%
Debt to Equity
0.16
Quarterly Earnings Growth YoY
-121.09%

Avalo Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025
RevenueN/A-$9.57M-$13.11M-$14.67M-$19.32M
Net Profit-$121.29M$98.46M$23.04M-$13.15M-$20.77M
Net Profit MarginN/A-1028.33%-175.72%89.64%107.50%
Income ChangeN/A181.18%-76.60%-157.08%-57.92%

Avalo Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
Revenue-$87.53M-$55.49M-$29.27M-$68.95M-$72.98M
Net Profit-$84.35M-$41.66MN/AN/AN/A
Net Profit Margin96.36%75.07%N/AN/AN/A
Income ChangeN/A50.61%N/AN/AN/A

About Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. Its lead asset includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.

Avalo Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$18.07
$18.34
+0.47%
Jul 2026
$18.64
$18.25
-1.19%
Jun 2026
$15.90
$18.47
+15.94%
May 2026
$13.43
$15.93
+18.79%
Apr 2026
$15.10
$13.41
-10.72%
Mar 2026
$16.91
$15.02
-14.56%
Feb 2026
$15.78
$17.58
+16.23%
Jan 2026
$17.75
$15.13
-16.64%
Dec 2025
$18.50
$18.14
-4.85%
Nov 2025
$18.03
$19.07
+7.13%
Oct 2025
$12.88
$17.80
+39.66%
Sep 2025
$9.07
$12.74
+38.99%

AVTX Share Price FAQs

What is Avalo Therapeutics, Inc. share price today?

chevron-up
Avalo Therapeutics, Inc. share price today is $18.34 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Avalo Therapeutics, Inc. stock?

chevron-up
The 52 week high of Avalo Therapeutics, Inc. stock is $24.23, while the 52 week low is $8.23 as of 8 Aug '26.

What is AVTX's market capitalisation today?

chevron-up
AVTX market capitalisation is $245.84M as of August 10, 2026, at 9:25 am IST.

What is AVTX's net income for the last quarter?

chevron-up
AVTX's net income for the last quarter is -0.02B USD.

What is the 5 year returns of AVTX?

chevron-up
The 5 year returns of AVTX is -99.79% as on 8 Aug '26.

What is the high & low stock price of AVTX today?

chevron-up
AVTX stock price hit a high of $18.86 and low of $17.90 as of 8 Aug '26.

Can I buy AVTX shares in India?

chevron-up
Yes. You can buy AVTX in India by opening an international trading account.